# Council Regulation (EU) No 557/2014 of 6 May 2014 establishing the Innovative Medicines Initiative 2 Joint Undertaking (Text with EEA relevance), Division 4: The States Representatives Group shall also provide information to, and act as an interface with, the IMI2 Joint Undertaking on the following matters:

Extent: E+W+S+N.I.

(a) the status of relevant national or regional research and innovation programmes and identification of potential areas of cooperation, including deployment, to allow synergies and avoid overlaps;
(b) specific measures taken at national level or regional level with regard to dissemination events, dedicated technical workshops and communication activities.

---
Source: https://www.legislation.gov.uk/eur/2014/557/annex/division/11/division/4 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-557/annex/division-11/division-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.